Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
22NW Fund, LP - 23 Dec 2024 SCHEDULE 13D/A Report for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR)
- Filing manager
- 22NW Fund, LP
- Reporting owner
- 22NW Fund, LP
- Beneficially owned shares
- 4,367,499 shares
- Class ownership
- 11%
- Large-stake signal
-
Ownership
11%
Beneficial ownership of this reported class.
Shares
4,367,499 shares
Shares beneficially owned as disclosed.
Event date
23 Dec 2024
Date tied to the ownership event or amendment.
Accepted by SEC
26 Dec 2024
EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- LFCR
- Shares outstanding
- 39,346,838 shares
- Form type
- SCHEDULE 13D/A
- Accepted by SEC
- 26 Dec 2024, 13:20:34 UTC
- Event date
- 23 Dec 2024
- Next filing
- 29 May 2025
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
SEC evidence
5 source fields
Key filing fact
22NW Fund, LP disclosed 11% ownership in Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR) on 23 Dec 2024.
Key facts
- 22NW Fund, LP filed SCHEDULE 13D/A for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR).
- Disclosed ownership: 11%.
- Date of event: 23 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Dec 2024, 13:20.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (7)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 22NW Fund, LP | 11% | 4,367,499 | 4,367,499 | 0 | 22NW Fund GP, LLC | General Partner | 0001640809 |
| 22NW, LP | 11% | 4,367,499 | 4,367,499 | 0 | 22NW GP, Inc., | General Partner | 0001694297 |
| 22NW Fund GP, LLC | 11% | 4,367,499 | 4,367,499 | 0 | /s/ Aron R. English | Manager | 0001770575 |
| 22NW GP, Inc. | 11% | 4,367,499 | 4,367,499 | 0 | /s/ Aron R. English | President and Sole Shareholder | 0001783663 |
| Aron R. English | 11% | 4,367,499 | 4,367,499 | 0 | /s/ Aron R. English | Individually and as attorney-in-fact for Nathaniel Calloway | 0001770436 |
| Bryson O. Hirai-Hadley | 0% | 583 | 583 | 0 | /s/ Bryson O. Hirai-Hadley | Bryson O. Hirai-Hadley | 0001888106 |
| Nathaniel Calloway | 0% | 34,315 | 34,315 | 0 | /s/ Aron R. English | As attorney-in-fact for Nathaniel Calloway | 0001952771 |
CIK / CUSIP context first